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Abstract
A breach of the skin barrier, due to a burn wound, facilitates colonization by various
microorganisms. Burn wounds can become colonized from the patients’ own skin flora,
respiratory tract, or with exogenous bacteria from the environment. Strategies to treat burn
wound infections are multipronged: removal of the infected necrotic tissue, wound dressing to
protect the damaged area, and treatment with specific antimicrobials to prevent reinfection.
The development of chronic infections, which could potentially lead to sepsis, depends largely
on how well the microorganisms form biofilms within the wound. There are numerous
antimicrobial gels and antibiotics that help prevent a burn wound from becoming infected, as
well as, eliminate an already infected burn wound. However, global antibiotic resistance by
microorganisms to these treatments has greatly increased, and it is imperative that new
antimicrobial agents be formulated before infections become untreatable. Staphylococcus,
Pseudomonas, Acinetobacter, Escherichia, Candida, Citrobacter, and Klebsiella are common
causative agents of burn wound infections and are becoming increasingly resistant to
antimicrobial medications. A newly synthesized antimicrobial gel compound (AGC) has shown
promise in preventing growth of various bacteria and fungi commonly associated with burn
wound infections. This study evaluated the activity of the AGC on a panel of Gram-positive and
Gram- negative bacteria, and the fungi, Candida albicans, which represent the top ten causative
infectious agents of burn wounds. The AGC reduced, to varying degrees, the microorganism’s
growth, cell viability, and cellular metabolism. This novel antimicrobial compound shows
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promising potential as an effective option for prevention and treatment of infections in burn
wound victims to avoid sepsis.

Introduction
Burn Wounds
Burn wounds are extremely different from other wounds, to the point that a separate medical
specialty has been designed to manage them. Heat from burns not only damages skin locally,
but also causes generalized effects on the body. The degree of the burn has an enormous
influence on how life-threatening the situation is (12). Acute burn wounds are a complex and
evolving injury, and extensive burns produce systemic consequences. Any adult burn over 15%
and pediatric burn over 10% will produce a hypovolemic shock due to the increase in capillary
permeability resulting in an extensive loss of plasma and whole blood loss. Burns can involve all
layers of skin as well as structures that are beneath such as muscle, bone, blood vessels, nerves,
and hair follicles (13). Burn wounds are classified into three different categories: first-degree
burn, second-degree burn, and third degree burn. In first-degree burns, or epithelial burns, the
skin is erythematic without vesication. Second-degree burns involve the epidermis with variable
thickness of the dermis. Second-degree burns can be further divided into second-degree
superficial and second-degree deep. Second-degree superficial burns have visible vesication
and inflammation, but only on the superficial portion of the dermis. Second-degree deep burns
penetrate the deep reticular dermis where eschar formation is seen. Third-degree burns, or full
thickness burns, produce eschar (12). Eschar is normally a dry, dark scab or dead skin shedding.
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Physicians and other healthcare personnel are more involved with the treatment of patients
with burn wounds than any other traumatic wound.

Microorganisms Associated with Burn Wounds
Bacterial colonization reaches as high as 86.6% of the isolates within the first week of infection.
Gram-negative microorganisms are more predominant; however, Staphylococcus aureus is the
most prevalent organism in the first week following the burn and is about 30% of the bacterial
isolates (7). By the third week, Staphylococcus aureus is closer to 10% of isolates while
Psuedomonas aeruginosa reaches about 30% of the isolates. This demonstrates how crucial it is
to treat a burn wound according to the specific microorganism(s) that colonize it because
microorganisms have different growth patterns. Thus, contamination of the burn wound is the
guideline rather than an exception in burn wounds (7). Biofilms can become established within
wounds in 5 hours and mature by 10 hours; therefore, the faster the wound acquires
medication the better the outcome for the individual (6, 8). Burn patients are at an extremely
high risk for infection, and about 75% of all burn wound deaths are related to infection (10).
Staphylococcus, Streptococcus, Pseudomonas, Acinetobacter, Escherichia, Candida, Citrobacter,
and Klebsiella are common causative agents of burn wound infections with increasing
resistance to many antimicrobial medications. For instance, Streptococcus pyogenes was the
most frequent cause of burn wound infections, which induced sepsis, early in the last century.
As of now, Staphylococcus aureus and Psuedomonas aeruginosa have become the most
frequent isolated organisms from wounds caused by burns due to their ability to effectively
evade certain medical treatments (7).
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Current Treatments for Infected Burn Wounds
Since ancient time, local and systemic remedies have been used for burn wounds. Death
associated with extensive burns is mainly due to wound infection as the patient becomes
immunocompromised from the burn (12). The gels that exist today do fight infection to
decrease the number of deaths caused by burns, but with increasing difficulty due to
resistance. One gel, Aloe vera inner gel, has made an astonishing impact as it can be used as an
antimicrobial, anti-inflammatory, lipid and glucose lowering agent, and has antioxidant
functions. This gel showed remarkable inhibition of H. Pylori and E. Coli strains (1). Next Science
Wound Gel Technology (NxtSc), is another topical agent that is designed to kill planktonic
bacteria, but this gel also can penetrate biofilms and kill the bacteria within. It works against
various bacterial infections that can lead to life threatening sepsis. The NxtSc has proven to
inhibit the growth of S. aureus and P. aeruginosa in infected wounds and eliminates other
gram-positive and gram-negative organisms from infected wounds (8). Guar gum is a new
antimicrobial peptide delivery system that helps fight against diabetic foot ulcers, which was
distinguishable in its ability to fight against Staphlococcus aureus in these foot ulcers (11). Nonaqueous glycerol monolaurate gel (GML) is another gel that fights Staphlococcus aureus
infections and is useful as a potent antibacterial and anti-inflammatory compound for
infections. GML is time-dependent when removing biofilms, with higher concentrations acting
at earlier time periods (14). Chitosan, a cationic natural polymer, can be used to prevent and
treat burn wounds because of its ability to deliver extrinsic antimicrobial agents to the site of
infection and its natural antimicrobial properties (4). Some synthetic skin substitutes that aid in
the antimicrobial healing process include Duoderm, Omniderm, Epigard, Biobrane, and
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Dermagraft. Commonly known topical antimicrobial antibiotics include Mafenide acetate,
Bacitracin, and Neosporin (3). Other types of interventions include burn wound dressings to
treat superficial and partial thickness burns. These dressings range from hydrocolloid and
polyurethane dressings to hydrogel and silicon-coated dressings (13). Though these are all
excellent, their effects are becoming nonexistent due to certain resistant bacteria. We present
here, an antimicrobial gel compound (AGC) that affects microorganisms commonly associated
with burn wounds. This new compound has proven to eliminate, or inhibit, specific microbial
growth of microorganisms such as Escherichia coli, Candida albicans, Citrobacter freundii,
Klebsiella pneumoniae, Pseudomonas aeruginosa, Serratia marcescens, and Enterobacter
cloacae. AGC not only decreased the microbial cell density and metabolism, but also decreased
the CFU’s on LB agar plates.

Materials and Methods
Strains & Culture Conditions
Bacteria utilized for experiments are listed in Table 1. All bacterial strains were purchased from
American Type Culture Collection (ATCC). Media for propagation and experiments involving
these strains was LB Miller broth (LB), a 10% (w/v) AGC broth with LB, or on LB agar plates.
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Microorganism

ATCC

Type of

Gram

Oxygen

Biofilm

strain microorganism reaction requirement Former
Candida albicans

10213

Eukaryote

N/A

Facultative
anaerobe

Yes

Citrobacter freundii

8090

Prokaryote

Negative

Facultative
anaerobe

Yes

Enterobacter

23355

Prokaryote

Negative

Facultative
anaerobe

Yes

Escherichia coli

25922

Prokaryote

Negative

Facultative
anaerobe

Yes

Klebsiella

13883

Prokaryote

Negative

Facultative
anaerobe

Yes

10145

Prokaryote

Negative

Facultative
aerobe

Yes

13880

Prokaryote

Negative

Facultative
anaerobe

Yes

cloacae

pneumoniae
Pseudomonas
aeruginosa
Serratia
marcescens
Table 1. Strains used in experiments

Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC)
Strains were inoculated in LB broth for 18 hours, at 37⁰C, with shaking (255rpm). These seed
cultures were used to inoculate, into varying concentrations of AGC-LB broth (0%-10% w/v), at
a final concentration of 1x106 cells/ml. These tubes were then incubated an additional 24
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hours. The MIC was determined visually by the lack of turbidity. Once the MIC was determined
aliquots from all AGC-LB broth tubes were plated onto LB agar plates. MBC was determined as
the lowest percentage plate that was void of growth.

Growth, Metabolism, and Viability Inhibition Assay
Strains were inoculated into LB broth for 18 hours, at 37⁰C, with shaking (255rpm). These seed
cultures were then used to inoculate LB broth (control) or 10% AGC-LB broth (experimental) at
a final concentration of 1x106 cells/ml. These tubes were then incubated an additional 24 hours
with shaking (255rpm). The cultures were added (100µl) to 96 well plate rows. Rows 1-6 were
used to measure the optical density (OD600) measurements of growth. Rows 7-12 were used for
optical density (OD570) measurements of metabolism of MTT. Briefly, 5µg/ml of MTT was added
to wells 7-12 and incubated at 37⁰C for 30 minutes. Acidic Isopropanol was added to stop the
reaction and optical density was then determined. Controls of LB broth only and 10% AGC-LB
only (no bacteria) were also added to the 96 well plate and treated, as above, to correct for
background and to act as a control. For determination of cell viability each condition was
serially diluted, plated on LB agar, and colony forming units (CFU) were enumerated.

Results and Discussion
AGC shows varying inhibitory MICs on bacteria commonly associated with burn wounds.
The minimum inhibitory concentration (MIC) is the lowest concentration of an antimicrobial
that will inhibit the visible growth of bacteria after incubation. Of the microorganisms tested
the concentration of bacterial cells grown with AGC was reduced when compared to the
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bacterial growth in the LB broth (0% AGC) control (Table 2). Candida albicans and Citrobacter
freundii displayed the lowest MIC at 3% AGC-LB broth concentrations. Serratia marscescens
demonstrated less turbidity when compared to the 0% control. However, there was growth in
all of the concentrations of AGC tested (0-10%); therefore, MIC was not determined.
Enterobacter cloacae (4%), Escherichia coli (6%), Klebsiella pneumoniae (6%), and Pseudomonas
aeruginosa (5%) all had varying MICs (Table 2). There appears to be no defining characteristic
that correlates with MIC among the tested microorganisms as there are representatives of
prokaryotes and eukaryotes, morphology, Gram classification, and oxygen requirements (Table
1). Additional work by our research group has shown that Staphylococcus aureus is highly
susceptible to the inhibitory effects of the AGC (data not shown).

AGC does not appear to have a cidal effect from the MBC concentrations tested.
The minimum bactericidal concentration (MBC) is the lowest concentration of an antibacterial
medication required to kill a specific bacterial strain. Only one of the microorganisms tested,
Escherichia coli at 9% AGC, had a detectable MBC (Table 3). All other microorganisms had
detectable growth when plated at all concentration dilutions, though growth was reduced. This
observation provides two possible explanations: (1) That AGC has bacteriostatic effects on
microorganisms and inhibits only growth, becasue there is no true MBC within the 10
concentrations tested; therefore, AGC may only serve as a compound that inhibits growth; (2)
that an increased percentage of AGC-LB is needed to determine the MBC. This potential
explanation may be considered in future experiments, however, we have only been successful
in a maximum 15% (w/v) AGC to LB broth formulation. Above this percentage, the AGC does
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not suspend in the LB broth. Additionally, rule-of-thumb for experiments is that the vehicle
(AGC) does not contribute more than 10% of the total volume. This takes into account effects
that any gel compound would impose on bacterial growth due to limiting the bacteria’s normal
requirements of growth (i.e. oxygen requirements).

AGC inhibits microorganism growth, cell metabolism, and cell viability.
Using the information from the MIC and MBC experiments, it was determined that the optimal
concentration for further experiments examining the microorganism’s growth, cellular
metabolism, and cell viability would be 10% AGC. A high throughput 96-well plate assay was
developed to allow for testing of all three conditions simultaneously. Microorganisms were
inoculated (1x106 cells/ml) and incubated overnight in LB broth with or without 10% AGC. These
cultures were then aliquoted equally into rows of 96-well plates. Wells 1-6 were used to obtain
optical density (OD600) readings for growth analysis. Wells 7-11 were used to obtain optical
density (OD570) readings for the reduction of MTT to formazan, to measure cell metabolism.
Well 12 was untreated and used to serially dilute the sample and plate on LB agar to enumerate
CFU data, to measure cell viability. In regards to optical density, or microbial growth density, all
microorganisms tested in the presence of 10% AGC displayed significant reduction in optical
density (Figure 1). Escherichia coli and Citrobacter freundii had the largest decreases in optical
density, 92% and 75% reduction respectively, as compared to their controls, whereas, Candida
albicans had the smallest decrease in optical density growth, 29%. Optical density readings
only identify the density of growth based on turbidity. Optical density cannot identify the state,
alive or dead, of the cells contained within the solution. We therefore turned our attention to
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CFU methods of determining the state of the microorganisms. Samples of each of the microbial
growth, with and without 10% AGC, were used to dilute out and plate on LB agar plates. In
theory, a single viable, alive, microorganism has the ability to grow into a colony. Once colonies
are enumerated they can be compared between control and experimental conditions. The
bacterial growth on LB plates differed tremendously between the AGC treated microbes and
the LB only microbes (see Table 4 for representative photographs). Bacterial growth on the
plates containing the LB broth with bacteria had growth up to dilutions of 109, but the plates
containing AGC treated bacteria were inhibited and most of the growth, if any, was not found
above dilution of 103 (Table 4). All microorganisms tested displayed decreased CFUs in
comparison to their untreated controls. In contrast to the optical density growth results,
Klebsiella pneumoniae had the largest decrease in CFUs at 90%. Candida albicans and
Escherichia coli, which had the largest optical density growth decrease had a more moderate
CFU decrease of 59% and 57%, respectively. This indicates that while Candida and Escherichia
are initially able to grow, shown by the increase in optical density, the AGC inhibits or damages
the cells, thus a decrease in viable cells to produce colony forming units is seen. Pseudomonas
aeruginosa, 41%, and Serratia marscescens, 35%, had the smallest decreases in CFU. This
correlates with the original MIC and MBC data, in that, the AGC for these two microorganisms,
in general, only inhibits their growth. The last assay performed, MTT reduction, tells us more
about the metabolism and viability of the microorganisms when treated with AGC. The yellow
compound MTT is reduced by actively metabolizing bacteria, via their mitochondria, to produce
a purple colored, reduced compound. The optical spectra can then measure the amount of
reduced product and when compared to viable untreated controls, can give information as to
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the metabolic activity of microorganisms. The cellular metabolism results were dramatic, with
all microorganisms having significant reductions in the ability to reduce the measured
compound. The metabolism of the bacteria not containing the AGC exhibited little to no
inhibition, whereas the bacterial sample containing the gel caused the cells metabolism to
come to a near halt with very little activity (Figure 3). However, as significant as these results
were, we had some interesting observations with this assay. When the MTT was added to the
AGC only control (no microorganisms present) we observed an almost immediate purple color
change. As this control is absent of bacteria, there should not have been a color change. The
MTT assay is based on a reducing reaction and there are a number of compounds and elements
that make up the AGC that have reducing activates. Therefore, we cannot accurately draw any
conclusions from this experiment on the viability of the microorganisms in regards to their
metabolic activity. Further experiments will need to be conducted with different ingredients of
the AGC, which cause reducing activity, removed so that better conclusions can be made as to
viability in regards to metabolism.

Conclusion
About 2 million fires are reported every year in the United States, resulting in, 1.2 million
people burned. In patients with severe burns, which cover more than 40% of the total body
surface area (TBSA), 75% of deaths are currently related to sepsis from burn wound infection,
other infection complications, and/or inhalation injury (2). There are many bacteria that
colonize burn wounds that can potentially lead to septic shock and death such as,
Staphylococcus, Pseudomonas, Acinetobacter, Escherichia, Candida, Citrobacter, and Klebsiella;
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which are becoming more resistant to antimicrobial medications. Due to this increased
resistance in microorganisms to current medications and treatments, a new treatment method
is essential. The AGC examined in this study shows ability to reduce growth and viability of a
variety of microorganisms commonly associated with burn wound infections. The activity of the
AGC, at this point, can best be categorized as a bacteriostatic, growth inhibiting, agent. This
inhibition is apparent in the low MIC ranges, but continued growth during the MBC ranges that
were tested was seen. Supporting this, CFUs, albeit low for some bacteria were still present
when using the highest concentration of AGC, 10%, tested. The results of these tests indicate
that AGC could potentially be a powerful tool for the prevention of infection of burn wounds or
be used to inhibit infected burn wound growth by microorganisms. If AGC is truly a
bacteriostatic compound it may not elicit the selective pressure on microorganisms to develop
drug resistance. In this case, AGC could prove to be a potentially lifesaving treatment for those
individuals suffering from burn wounds.

14

Microorganism 0%

1%

Candida

2%

3%

4%

5%

6%

7%

8%

9%

MIC
3%

albicans

Citrobacter

3%

freundii

Enterobacter

4%

cloacae

Escherichia coli

6%

Klebsiella

6%

pneumoniae
Pseudomonas

5%

aeruginosa

Serratia

*

marscescens

Table 2. Determination of the MIC of bacteria associated with burn wounds when exposed to
varying concentrations of AGC.

15

Microorganism

MBC

Candida

>10%

albicans

Citrobacter

>10%

freundii

Enterobacter

>10%

cloacae

Escherichia coli

9%

Klebsiella

>10%

pneumoniae

Pseudomonas

>10%

aeruginosa

Serratia

*

>10%

marscescens
Table 3. Determination of MBC of bacteria associated with burn wounds when exposed to
varying concentration of AGC.
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Figure 1. Optical density (OD600) graph of microorganism growth with or without 10% AGC.
Standard deviation bars shown.
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Microorganism

Control (No AGC)

Experimental
(10% AGC)

Candida

*

*

*

*

albicans
Citrobacter
freundii
Enterobacter
cloacae
Escherichia coli
Klebsiella
pneumoniae
Pseudomonas
aeruginosa
Serratia
marscescens
Table 4. CFU determination of microorganisms without AGC and with AGC
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Figure 2. Logarithmic graph of CFU experiments of microorganisms grown with or without
10% AGC.
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Figure 3. Graph of cell respiration using MTT assay on microorganisms grown with or without
10% AGC. Standard deviation bars shown.
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